Lipidstoffwechsel

Sie befinden sich hier:

Lipidstoffwechsel

Autor

Titel/Link

Jahr

Journal

Abella et al.

Leptin in the interplay of inflammation, metabolism and immune system disorders.

2017

Nature reviews. Rheumatology

Giuranna et al.

Genetische Ursachen der Adipositas

2017

Der Gastroenterologe

Heymsfield and Wadden

Mechanisms, Pathophysiology, and Management of Obesity.

2017

The New England journal of medicine

Karathanasis et al.

The Changing Face of HDL and the Best Way to Measure It.

2017

Clinical chemistry

Khvorova

Oligonucleotide Therapeutics - A New Class of Cholesterol-Lowering Drugs.

2017

The New England journal of medicine

McGarrah et al.

A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.

2017

Clinical chemistry

Miller and Shyy

Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation.

2017

Trends in endocrinology and metabolism: TEM

Abdullahi and Jeschke

White Adipose Tissue Browning: A Double-edged Sword.

2016

Trends in endocrinology and metabolism: TEM

Ajufo and Rader

Recent advances in the pharmacological management of hypercholesterolaemia.

2016

Lancet Diabetes Endocrinol

Cingolani and Czaja

Regulation and Functions of Autophagic Lipolysis.

2016

Trends in endocrinology and metabolism: TEM

Cushman and Goff

More HOPE for Prevention with Statins.

2016

N Engl J Med

Hai and Zuo

Aberrant DNA methylation in the pathogenesis of atherosclerosis.

2016

Clin Chim Acta

Han

Lipidomics for studying metabolism.

2016

Nature reviews. Endocrinology

Ioannou

The Role of Cholesterol in the Pathogenesis of NASH.

2016

Trends Endocrinol Metab

Jin et al.

Apoprotein C-III: A review of its clinical implications.

2016

Clinica chimica acta; international journal of clinical chemistry

Kotani et al.

Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions.

2016

Critical reviews in clinical laboratory sciences

Mammen

Statin-Associated Autoimmune Myopathy.

2016

N Engl J Med

Nordestgaard et al.

Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

2016

Clinical chemistry

Pownall and Gotto

New Insights into the High-Density Lipoprotein Dilemma.

2016

Trends Endocrinol Metab

Ramasamy

Update on the molecular biology of dyslipidemias.

2016

Clin Chim Acta

Santos et al.

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.

2016

The lancet. Diabetes & endocrinology

Stancel et al.

Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.

2016

Clin Chem

Vaziri

HDL abnormalities in nephrotic syndrome and chronic kidney disease.

2016

Nat Rev Nephrol

Wald et al.

Child-Parent Familial Hypercholesterolemia Screening in Primary Care.

2016

The New England journal of medicine

Xue-Shan et al.

Imbalanced cholesterol metabolism in Alzheimer's disease.

2016

Clin Chim Acta

Yang and Han

Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.

2016

Trends in biochemical sciences

Zhong et al.

Sortilin: A novel regulator in lipid metabolism and atherogenesis.

2016

Clinica chimica acta; international journal of clinical chemistry

Apostolopoulou et al.

The role of mitochondria in statin-induced myopathy.

2015

Eur J Clin Invest

Eren et al.

HDL functionality and crystal-based sterile inflammation in atherosclerosis.

2015

Clin Chim Acta

Grundy

Adipose tissue and metabolic syndrome: too much, too little or neither.

2015

Eur J Clin Invest

Gulati and Merz

New cholesterol guidelines and primary prevention in women.

2015

Trends Cardiovasc Med

Kobayashi and Mabuchi

Lipoprotein lipase and atherosclerosis.

2015

Annals of clinical biochemistry

Langsted and Nordestgaard

Nonfasting Lipid Profiles: The Way of the Future.

2015

Clin Chem

Opie

Present status of statin therapy.

2015

Trends Cardiovasc Med

Saleheen et al.

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.

2015

Lancet Diabetes Endocrinol

Tall and Yvan-Charvet

Cholesterol, inflammation and innate immunity.

2015

Nat Rev Immunol

van Tienhoven-Wind and Dullaart

Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders.

2015

Eur J Clin Invest